hpayette
Congratulations to the BCWH Penicillin Allergy Delabelling Clinic on receiving the BC Quality Award for “Optimizing the Early Years”!
The BCWH Penicillin Allergy Delabelling Clinic, whose team includes RID Program team members Dr. Chelsea Elwood, Dr. Julie van Schalkwyk, and Dr. Jeffrey Wong has recently been awarded the BC Quality Award for exemplary health care in the category of “Optimizing the Early Years” by Health Quality BC!
New HPV Screening Algorithm and Guidelines Released for Immunocompromised Women and Gender-Diverse People with a Cervix in BC!
Two new resources have been released that were co-developed by the team at the RID Program, to help answer questions regarding the HPV screening protocols for women and gender-diverse people with a cervix living with HIV, as well as other immunocompromised individuals.
Check Out the RID Program on Instagram and Facebook!
The RID Program has recently launched a new Instagram and Facebook account.
REACT-Syph Project Team Attends the 2024 BC Provincial Perinatal Substance Use Conference to Distribute Resources on Congenital Syphilis and Syphilis in Pregnancy as Part of Ongoing Knowledge Mobilization Efforts!
RID Program team members Emma Karlsen and Roisin Delaney attended as exhibitors to help showcase the ongoing work of the RID Program’s REACT-Syph (Towards the Eradication of Congenital Syphilis in Canada: Canadian Maternal and Congenital Syphilis Surveillance) Project
New Report Released from the RID Program’s CANCOVID-Preg Project!
The RID Program’s Canadian Surveillance of COVID-19 in Pregnancy: Epidemiology, Maternal and Infant Outcomes (CANCOVID-Preg) Project has just released a new report (Report #7) on some of the most recent updates, key findings and recommendations based on the latest data.
New Publication: “Reliability and validation of an electronic penicillin allergy risk-assessment tool in a pregnant population” Accepted by Allergy, Asthma & Clinical Immunology!
A new publication from a team of authors that includes multiple members of the RID Program, including Dr. Chelsea Elwood, Dr. Julie van Schalkwyk, and Melissa Watt has been accepted by Allergy, Asthma, & Clinical Immunology and will be published in a future issue of the journal!
New Publication: “Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study” published in Vaccine!
A new publication from the RID Program team on the findings of the COVERED Project’s Immune Sub-Study has been published in Vaccine!
New Publication: “Antepartum versus postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two-center prospective cohort study” Published in Acta Obstetricia et Gynecologica Scandinavica!
A new publication authored by RID Program team members entitled “Antepartum versus postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two-center prospective cohort study” has been published in Acta Obstetricia et Gynecologica Scandinavica!
Register Now for the International Workshop on HIV & Women 2025!
Registration is now open for the 2025 iteration of the annual International Workshop on Women & HIV, which is being held from April 11-12, 2025 in Barcelona, Spain as well as virtually!
New Government of Canada Travel Recommendations for Pregnant Women and People Regarding Outbreaks of Oropouche Virus Disease
Due to increased case numbers and particular risks of negative impacts for pregnant women and people of Oropouche Virus Disease, the Government of Canada has released travel recommendations for pregnant women and people going to countries with active outbreaks.